Cargando…
Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice
High Drinking in the Dark (HDID-1) mice represent a unique genetic risk model of binge-like drinking and a novel means of screening potential pharmacotherapies to treat alcohol use disorders (AUDs). We tested the effects of tacrolimus (0, 0.5, 1, and 2 mg/kg), sirolimus (0, 5, 10, and 20 mg/kg), pal...
Autores principales: | Grigsby, Kolter B, Savarese, Antonia M, Metten, Pamela, Mason, Barbara J, Blednov, Yuri A, Crabbe, John C, Ozburn, Angela R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705291/ https://www.ncbi.nlm.nih.gov/pubmed/33294845 http://dx.doi.org/10.1177/2633105520975412 |
Ejemplares similares
-
Ethanol Conditioned Taste Aversion in High Drinking in the Dark Mice
por: Crabbe, John C., et al.
Publicado: (2019) -
Do non-drinking youth drink less alcohol in young adulthood or do they catch up? Findings from a Swedish birth cohort
por: Larm, Peter, et al.
Publicado: (2023) -
Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice
por: Crabbe, John C., et al.
Publicado: (2020) -
Ethanol-Related Behaviors in Mouse Lines Selectively Bred for Drinking to Intoxication
por: Jensen, Bryan E., et al.
Publicado: (2021) -
Corticosterone Levels and Glucocorticoid Receptor Gene Expression in High Drinking in the Dark Mice and Their Heterogeneous Stock (HS/NPT) Founder Line
por: Savarese, Antonia M., et al.
Publicado: (2022)